Arrow Pharmaceuticals re-entered the Australian market following the Strides purchase of the Chemists’ Own Brand and Aspen Australia Generics business in 2015. Although Arrow re-entered the market under new owners and the industry has changed significantly in sixteen years, the passion and determination to drive innovation remains in the DNA of the Arrow name, its people and the business.
Backed by the global strength of Strides and working off a strong foundation, Arrow is committed to supporting the future of Australian Retail Pharmacy and the communities they serve through its rapidly expanding portfolio of products, strategic partnerships and specialised engagement platforms.
Headed by Chairman Dennis Bastas, Arrow Pharmaceuticals brings together a team of industry professionals with incomparable experience across R&D, business development, professional services, sales and marketing.
The information on this website is intended for health care professionals only. Product information is for educational purposes only, and not all products or indications are licensed in every country. Product availability are subject to individual country license, rules, and regulations. The information on this website may not be reflecting the most updated information. Please contact directly for the most updated product information and availability.